Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls.
Adolescent
Age of Onset
Capillaries
/ abnormalities
Case-Control Studies
Child
Cross-Sectional Studies
Evaluation Studies as Topic
Female
Hemorrhage
/ diagnosis
Humans
Lupus Erythematosus, Systemic
/ complications
Male
Microscopic Angioscopy
/ methods
Nails
/ blood supply
Scleroderma, Systemic
/ diagnosis
Severity of Illness Index
Vascular Malformations
/ diagnosis
Capillaroscopy
case-control
childhoodonset
pediatric
systemic lupus erythematosus
Journal
Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
5
3
2021
medline:
7
10
2021
entrez:
4
3
2021
Statut:
ppublish
Résumé
For selection of high-risk systemic lupus erythematosus (SLE) patients it is necessary to obtain indicators of disease severity that predict disease damage. As in systemic sclerosis, nailfold capillary abnormalities could be such a biomarker in SLE. The primary objective of this cross-sectional study is to describe capillary abnormalities in childhood-onset SLE (cSLE) cohort (onset < 18 years) and compare them with matched healthy controls. The secondary objective is to correlate the observed capillary abnormalities with demographical variables in both cohorts and with disease-specific variables in cSLE patients. Healthy controls were matched for ethnic background, age and gender. Videocapillaroscopy was performed in eight fingers with 2-4 images per finger. Quantitative and qualitative assessments of nailfold capillaroscopy images were performed according to the definitions of the EULAR study group on microcirculation in Rheumatic Diseases. Both groups (n = 41 cSLE-patients and n = 41 healthy controls) were comparable for ethnic background (p = 0.317). Counted per mm, cSLE-patients showed significantly more 'giants' (p = 0.032), 'abnormal capillary shapes' (p = 0.003), 'large capillary hemorrhages' (p < 0.001) and 'pericapillary extravasations' (p < 0.001). Combined 'abnormal capillary shapes and pericapillary extravasations' (in the same finger) were detected in 78% (32/41 patients). By qualitative analysis, 'microangiopathy' was detected in 68.3% (28/41) and a 'scleroderma pattern' in 17.1% (7/41) of the cSLE-patients (without scleroderma symptoms). The difference of percentage positive anti-RNP antibodies in the group with or without a scleroderma pattern was not significant (p = 0.089). The number of 'abnormal capillary shapes per mm' was significantly correlated with treatment-naivety. The number of 'large pathological hemorrhages per mm' was significantly correlated with SLEDAI score and presence of nephritis. Compared to healthy controls, 'pericapillary extravasations' were found in significantly higher numbers per mm (p < 0.001) as well as in percentage of patients (p < 0.001). Our observations confirm that giants, abnormal capillary morphology and capillary hemorrhages are also observed in cSLE, as was already known for adults with SLE. Number of capillary hemorrhages in cSLE was significantly correlated with disease activity. A high frequency and total amount of "pericapillary extravasations" was observed in cSLE patients, possibly revealing a new subtype of capillary hemorrhage that might reflect endothelial damage in these pediatric patients.
Identifiants
pubmed: 33657918
doi: 10.1177/0961203321998750
pmc: PMC8020305
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
818-827Références
Arthritis Rheum. 1980 Feb;23(2):183-9
pubmed: 7362667
Clin Rheumatol. 2013 Jun;32(6):839-43
pubmed: 23417347
Ann Rheum Dis. 2014 Jun;73(6):958-67
pubmed: 24739325
Autoimmun Rev. 2020 Mar;19(3):102458
pubmed: 31927087
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Semin Arthritis Rheum. 1990 Aug;20(1):21-31
pubmed: 2218550
Lupus. 2017 Aug;26(9):959-966
pubmed: 28056626
RMD Open. 2017 Oct 25;3(2):e000508
pubmed: 29119007
Am J Med. 1992 Dec;93(6):619-27
pubmed: 1466357
Autoimmun Rev. 2019 Nov;18(11):102394
pubmed: 31520797
Clin Rheumatol. 2017 Feb;36(2):343-350
pubmed: 28012055
Autoimmun Rev. 2018 Apr;17(4):344-352
pubmed: 29427827
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
RMD Open. 2018 Nov 27;4(2):e000793
pubmed: 30564454
Ann Rheum Dis. 2012 Oct;71(10):1636-9
pubmed: 22402146
Semin Arthritis Rheum. 1999 Aug;29(1):36-42
pubmed: 10468413
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):350-354
pubmed: 31858964
Semin Arthritis Rheum. 2010 Feb;39(4):257-68
pubmed: 19136143
Lupus Sci Med. 2018 May 14;5(1):e000237
pubmed: 29765616
Rheumatology (Oxford). 2007 Oct;46(10):1566-9
pubmed: 17693443
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i67-i77
pubmed: 27940583
Semin Arthritis Rheum. 2019 Oct;49(2):267-272
pubmed: 31235075
Ann Rheum Dis. 2009 Jan;68(1):94-8
pubmed: 18308744
Lupus. 2015 Oct;24(12):1342-9
pubmed: 26085595
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):788-94
pubmed: 26575830
Rheumatology (Oxford). 2018 Apr 1;57(4):757-759
pubmed: 29361155
Lupus. 2016 Dec;25(14):1542-1550
pubmed: 27147622
J Rheumatol. 2002 Jul;29(7):1398-400
pubmed: 12136895
Arthritis Rheum. 1973 Sep-Oct;16(5):619-28
pubmed: 4742842
Autoimmun Rev. 2017 Aug;16(8):774-786
pubmed: 28572048
Biomed Res Int. 2014;2014:178721
pubmed: 24790989
Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68
pubmed: 31172926
Rheumatol Int. 2016 Jul;36(7):955-60
pubmed: 26979603
Rheumatology (Oxford). 2016 May;55(5):883-90
pubmed: 26843483
J Rheumatol. 2013 Dec;40(12):2023-8
pubmed: 24128778
J Clin Rheumatol. 2005 Dec;11(6):295-8
pubmed: 16371797
Ann Rheum Dis. 2008 Jun;67(6):885-7
pubmed: 18037628
Pediatr Rheumatol Online J. 2019 Oct 24;17(1):69
pubmed: 31651352